Medeologix Partners with Biocoat to Add Hydrophilic Coating Services

Medeologix, a US medical device manufacturing brand, announced a significant expansion of its end-to-end catheter solutions with the addition of hydrophilic coating services, further solidifying its position as the Bay Area's top choice for advanced catheter solutions.

The expansion is the result of a partnership with Biocoat, a supplier of hydrophilic coating materials with a mature FDA master file that streamlines regulatory approvals. It also demonstrates Medeologix's commitment to providing premium, innovative coating solutions for cutting-edge catheter technologies.

For more than two decades, Medeologix has grown with its customers, providing the medical device industry with one-stop services from concept to mass production. Solutions include in-house extrusion, medical balloon molding, complex catheter manufacturing, PET heat shrink tubing, overmolding, secondary operations, and finished device solutions.

The expansion of hydrophilic coating services reinforces Medeologix's commitment to providing comprehensive, one-stop catheter development and manufacturing services. The company's unique advantage lies in its vertically integrated approach, which incorporates hydrophilic coatings directly into the catheter processing workflow. This integrated service model is designed to improve efficiency, quality, and cost-effectiveness for customers.

“Our partnership with Biocoat is a game changer,” said Albert Weng, Chief Development Officer at Medeologix. “It allows us to not only offer speed and efficiency to our customers, but also the assurance of using industry-leading coating materials backed by strong regulatory support.”

“By integrating hydrophilic coating services into our existing catheter production line, we are delivering a lightning-fast solution with unprecedented efficiency. This advancement allows us to offer an unmatched combination of speed and consistency to our customers in the Bay Area and beyond.”